AI is not just transforming data—it’s redefining how we understand the human body. What once seemed impossible in precision nutrition—decoding the complex interplay of genes, biomarkers, and metabolism—is now within reach.

Pioneers like Viome Life Sciences (AI + RNA, $175M funded) are proving the power of intelligent nutrition, using RNA sequencing to detect early health risks and deliver personalized dietary solutions that have clinically reduced IBS symptoms by 58% and anxiety by 31%.

In this new era, AI becomes more than a tool—it’s the nutritionist’s “cyber colleague,” bridging science and human vitality in ways never before imagined.

For decades, the nutrition industry has been built on a model of standardized products and mass consumption, with functional foods and FMCG systems driving scale through ingredients, formats, and branding. Today, that model is being fundamentally reshaped.

Rising demand for chronic disease management, increasingly sophisticated consumers, and the rapid advancement of data, digital health, and AI technologies are accelerating a shift from “one-size-fits-all” nutrition toward personalized, data-driven health solutions. Nutrition is no longer just about products—it is evolving into integrated systems that combine assessment, data, intervention, and ongoing health management.

“Let food be thy medicine,” the timeless principle of Hippocrates, the father of Western medicine, has shaped Europe’s approach to daily self-care for centuries. Elderberry anthocyanins, a flagship ingredient within this food-as-medicine tradition, have long been used to support the body through seasonal changes and everyday health maintenance.

In November 2025, elderberry anthocyanins were officially approved as a new food ingredient in China, marking the beginning of their legitimate application in the domestic functional food market and opening new opportunities for immune health and cross-category innovation. In the European and U.S. markets, elderberry has already established itself as a top-selling immune-support ingredient, backed by scientific research and consumer recognition. Its polyphenols also modulate gut microbiota, offering “non-traditional prebiotic” potential, extending its benefits from seasonal immune support to daily health management.

Tonic and food-as-medicine products have long been seen as high-barrier, low-frequency offerings for a niche group of informed consumers. Leveraging Hema’s retail ecosystem, supply chain capabilities, and data-driven insights, 「Hebubu」 applies modern FMCG logic to reframe traditional tonics into everyday, easy-to-use functional foods. This shift is helping move the category from an elite niche into everyday life—and redefining how tonic and functional foods can scale for the mass market.

By the end of 2024, China’s population aged 60 and above had reached 310 million, marking the silver economy’s entry into an unprecedented golden era. Unlike the past, when the focus was primarily on extending lifespan, today’s consumers aspire to “not just live longer, but live better.” Under the concept of active aging, the silver economy’s audience is expanding to younger groups who value functional health, quality of life, and emotional fulfillment.

This shift not only represents a vast opportunity for the health and elderly care industries, but also signals the continuous emergence of new products, services, and lifestyle scenarios.

Cellular health is the cornerstone of longevity science, and mitochondrial decline—as the cell's energy hub—is one of the core hallmarks of aging. As nutritional intervention enters the molecular era, bypassing biological barriers to achieve precision intervention for specific organelles has become the key to extending healthspan.

What are the core mechanisms of mitochondrial targeting technology? How can scientific innovation be transformed into tangible consumer value? These are the essential questions that brands and products must answer in this new era of cellular health.

As sports nutrition evolves from simple “supplementation” to science-driven performance intervention, M-ACTION is pioneering a systematic R&D approach that fills a critical gap in China’s professional sports nutrition market. Grounded in energy-metabolism mechanisms, diverse training scenarios, and empirical data from professional athletes, M-ACTION has built a comprehensive development framework covering ingredient selection, efficacy validation, scenario-based product design, and performance evaluation.

This session will explore how M-ACTION transforms scientific research into practical solutions that enhance athletic performance, accelerate recovery, and optimize energy utilization. It will also examine future innovation pathways for China’s sports nutrition landscape.

Creatine’s global rise illustrates how a niche functional ingredient can break out: originally focused on fitness and sports nutrition, it gained mass awareness through viral social media, especially TikTok, boosting category sales and brand penetration.

According to SPINS data for the 52 weeks ending December 29, 2024, total creatine supplement sales in the US reached $378 million, representing a 22% CAGR from 2023–2024, with gummies being the standout growing at 360% YOY $ growth.

In the probiotic world, Akkermansia muciniphila (AKK) has emerged as a hot “dark horse.” Beyond supporting gut barrier integrity and immune regulation, it shows transformative effects on metabolic health, weight management, and inflammation control. Multiple studies link AKK directly to reduced obesity and diabetes risk, earning it recognition as a next-generation probiotic.

On June 26, 2025, Danone made a major investment to acquire Belgium’s The Akkermansia Company, fast-tracking the commercial rollout of this star strain. From premium functional yogurts to precision nutrition packs and future personalized health solutions, AKK is moving from research papers straight into consumers’ carts. This represents not only a convergence of scientific innovation and capital strategy but also a potential starting point for the next wave of global gut health market growth.